论文部分内容阅读
对104例心律失常患者用钛黄法作血清镁测定,并设60例正常人为对照组。结果:对照组血镁X±SD 1.054±0.013mmol/L。104例心律失常组血镁与对照组无显著差别。若将心律失常根据有无CHF分组,则其中43例CHF伴心律失常患者血镁X±SD为0.956±0.022mmol/L,明显低于对照组(P<0.05)。在伴洋地黄中毒及低血钾者尤为明显。从而提示在抗心律失常的治疗中,要重视镁制剂的应用。
104 cases of arrhythmia patients with titanium yellow method for the determination of serum magnesium, and set 60 normal control group. Results: The control group, the blood magnesium X ± SD 1.054 ± 0.013mmol / L. 104 cases of arrhythmia group of magnesium and control group no significant difference. If the arrhythmia group according to the presence or absence of CHF, 43 cases of CHF with arrhythmia in patients with blood magnesium X ± SD was 0.956 ± 0.022mmol / L, significantly lower than the control group (P <0.05). In with digitalis poisoning and hypokalemia were particularly evident. Which prompted the anti-arrhythmia treatment, we should pay attention to the application of magnesium preparations.